Effect of vitrification on morphology and in-vitro maturation outcome of human immature oocytes by Mohsenzadeh, Mehdi et al.
© 2011 Firenze University Press 
ht tp://www.fupress .com/ijae
ItalIan Journal of anatomy and Embryology
IJAE 
Vo l .  117,  n .  3 :  19 0 -198 ,  2012
Research Article - Histology and Cell Biology
Effect of vitrification on morphology and in-vitro 
maturation outcome of human immature oocytes 
Mehdi Mohsenzadeh1, Mohammad Ali Khalili2,*, Saeedeh Nazari2, Vahid Hemayatkhah Jahromi3, 
Azam Agharahimi2, Iman Halvaei2
1 Shiraz University of Medical Sciences, Shiraz, Iran. 
2 Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
3 Department of Biology, Jahrom Branch, Islamic Azad University, Jahrom, Iran. 
Submitted November 30, 2011; accepted April 16, 2012
Summary
Background. In assisted reproductive techniques, 85% retrieved oocytes are mature, and the rest 
are immature. These immature oocytes may be matured in vitro, and used in subsequent in 
vitro fertilization program. The purpose of this study was to determine the maturation capac-
ity and morphology of human immature oocytes in both fresh and vitrified-thawed, in vitro 
matured oocytes with regard to the maternal age and cause of infertility.
Materials & Methods. The first group of immature oocytes (n=103) were directly matured in vitro 
(fIVM), and the second group (n=102) were vitrified and stored in liquid nitrogen. After thaw-
ing, the samples underwent in vitro maturation (vIVM). Oocyte maturation was assessed by the 
presence of the 1st polar body and pronuclei. After 48 h incubation, each matured oocyte was 
assessed for ooplasm color, periviteline space normality and shape regularity.
Results. After retrieval, 27% oocytes were immature (9.5 % metaphase I and 17.5% germinal ves-
icle stage). The rate of maturation of fIVM (61.2%) was significantly higher than that of vIVM 
(33.3%). The percentage of maturation in women under age of 30 was higher in both fIVM and 
vIVM. The maturation rate after IVM was higher in patients with male infertility than in those 
suffering of ovarian infertility.
Conclusion. Vitrification is a suitable technique for preservation of immature oocytes, especially 
at the germinal vesicle stage, in stimulated ovarian cycles. It should be noted that the maturation 
outcome of oocytes at germinal vesicle stage was better than that of metaphase I oocytes. There-
fore, we recommend vitrifying germinal vesicle stage oocytes for subsequent in vitro maturation.
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Introduction
In vitro maturation (IVM) of immature oocytes has been proposed as an alternative 
for conventional in vitro fertilization (IVF) treatment in certain cases. IVM has sev-
eral advantages of reducing costs, avoiding the side effects of ovarian hyperstimula-
tion syndrome and simplifying treatment for certain infertile couples (Al-Hasani et al., 
2007; Liu et al., 2010; Ben-Ami et al., 2011). Thus, IVM would avoid the high amounts 
of exogenous gonadotropins required for controlled ovarian hyperstimulation.
During the last decade, considerable progress has been made in the development 
of protocols for cryopreservation of mature oocytes. Also, there are practical applica-
tions for freezing immature oocytes, including fertility preservation for young cancer 
patients or patients without a male partner and contra-indication to ovarian stimu-
lation in cases of hormone-sensitive tumors (Fuchinoue et al., 2004; Cobo et al., 2008; 
Homburg et al., 2009). Immature oocyte cryopreservation may also prove beneficial 
during routine assisted reproductive techniques in combination with IVM. The use of 
these oocytes for cryopreservation may circumvent some of the limitations associated 
with freezing of mature oocytes, specifically relating to the functional integrity of the 
meiotic spindle and ploidy of resulting embryos (De Vos et al., 1999; Yoon et al., 2001; 
Hreinsson and Fridström, 2004; Ben-Ami et al., 2011). IVM before freezing may render 
the oocyte even more vulnerable to damages associated with cryopreservation, given 
that IVM per se undoubtedly imposes additional stress on the oocyte. Therefore, it is 
more logical to freeze immature oocytes prior to IVM (Wu et al., 2001; Cao et al., 2009).
Past clinical studies with germinal vesicle stage (GV) oocytes as well as vitrifica-
tion protocols have documented wide variability of results for survival, maturation, 
fertilization, and pre-implantation embryo development (Moor et al., 1998; Kim et al., 
2000; Wu et al., 2001; Liu et al., 2010; Ben-Ami et al., 2011). However, there are lim-
ited reports of vitrification of human GV oocytes. Most recently, Fasano et al. (2010) 
reported, for the first time, a side-by-side comparison of GV oocyte cryopreservation 
by either slow-freezing or vitrification (Fasano et al., 2010). Further investigations 
are therefore needed on immature oocyte cryopreservation, together with matura-
tion evaluation. Vitrification is an attractive alternative to slow freezing methods. It 
requires both ultra rapid cooling rates and very high cryoprotectant concentrations to 
prevent ice crystal formation and to increase viscosity at low temperatures. A series 
of successful live births has been recently reported after IVM of vitrified-thawed 
oocytes (Mandelbaum et al., 1988; Baka et al., 1995). In contrast, at least one child was 
born with the use of slow cryopreserved GV oocytes that subsequently underwent 
IVM protocol before intracytoplasmic sperm injection (Fasano et al., 2010). 
The main objective of this prospective study was to investigate the impact of cryo-
preservation by vitrification on the morphology and maturation success of immature 
human oocytes at the GV and meiotic metaphase I (MI) stages.
Materials and Methods
Patients 
A total of 89 infertile women, mean average age 32.3±6.3 years (range 19–41 
years), were included in this cross-sectional study. The patients were stimulated in 
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view of intracytoplasmic sperm injection with the standard long-term stimulation 
protocol using human menopausal gonadotropin and human chorionic gonado-
tropin injections. The immature oocytes were donated for research, with consent, 
by patients of Yazd Institute for Reproductive Science. Protocols were approved 
by the ethic committee of the authors’ institution. The oocytes were allocated in 
two groups: fresh-IVM (fIVM; n=103) and vitrified-IVM (vIVM; n=102). Infer-
tile patients were divided into three etiology groups: I. female infertility (n=25); 
II. male infertility (n=43); and III endometriosis + male infertility (n=21). Simul-
taneously, they were also divided into two age groups: ≤30 (n=50) and >30 (n=39) 
years old.
Immature oocyte retrieval
Oocytes were retrieved 36 h after 10,000 IU human chorionic gonadotropin (IBSA 
Co, Switzerland). Transvaginal ultrasound-guided puncture was used with a single 
lumen aspiration needle (Wallace, Smiths Medical International, UK), at a pressure 
of 150 mmHg. The collected oocytes were assessed for nuclear maturity under the 
stereo microscope (Olympus Co, Tokyo, Japan): cells in the germinal vesicle (GV) or 
metaphase I (MI) stages were considered immature. Oocytes with visible GV were 
considered in GV stage and those lacking both a polar body and a GV were con-
sidered at MI stage. After partial denudation with 80 IU hyaluronidase (Sigma Co, 
St. Louis, Mo, USA) and mechanical pipetting, the oocytes were assessed again for 
signs of maturity. Only the oocytes that were determined to be immature were used 
in this study. The first group of immature oocytes (n=103) were directly subjected to 
IVM (fIVM), and the second group of immature oocytes (n=102) were vitrified and 
stored in liquid nitrogen. After thawing, these oocytes also underwent IVM (vIVM). 
Before fIVM or vitrification, the morphology of all immature oocytes was evaluated 
with the aid of inverted microscope (Olympus). Both maturity and the morphologi-
cal characteristics of oocytes were assessed again after IVM. In this study, evalua-
tion of oocytes morphology was based on assessing: 1) ooplasm color; 2) perivitel-
line space (PVS) normality; and 3) oocyte shape. The total number of oocytes from 
89 patients was 968 including both mature and immature oocytes. 73% of retrieved 
oocytes were mature (in meiotic metaphase II), while the rest were immature oocytes 
(9.5% MI and 17.5% GV). 
IVM of immature oocytes
Denuded oocytes were washed in 3 drops of culture medium, then cultured in 
IVM medium consisting of: Ham’s F10 (Biochrom Co, Germany) supplemented with 
0.75 IU LH, 0.75 IU FSH (Menogon, Ferring Co, Germany) and 40% follicular fluid 
(FF), as described previously (Wu et al., 2001). Briefly, FF was centrifuged at 300 g for 
10 min to remove blood and granulosa cells. After inactivation at 56 °C for 30 min, 
the clear FF was filtered with a 0.22 µm filter and stored at -20 °C before use. The 
oocytes were evaluated for maturity after 48 h at 37 °C in an incubator with 5% CO2 
and 95% air, with high humidity. Oocyte maturation was assessed by the presence of 
the first polar body under a dissecting microscope. 
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Vitrification and thawing of Immature Oocytes
Vitrification and thawing were performed according to a previously published 
protocol (Al-Hasani et al., 2007). The immature oocytes were incubated in equilibra-
tion solution comprising of 7.5% ethylene glycol (EG) (Merck Co, Germany) and 7.5% 
dimethyl sulphoxide (DMSO) (Merck Co, Germany) in Ham`s F-10 media supple-
mented with 20% human serum albumin (HSA) (Plasbumin Co, USA) for 5-15 min 
(depending on the time needed for re-expansion of the cell) at room temperature. 
After initial shrinkage and recovery, the oocytes were aspirated and placed into the 
vitrification solution (15% EG, 15% DMSO, 0.5 M sucrose) in Ham’s F-10 medium sup-
plemented with 20% HSA for 50-60 s at room temperature. During vitrification, after 
observing cellular shrinkage, oocytes were aspirated and placed on the tip of the Cry-
otops (Kitazato BioPharma Co., Japan), which were immediately transferred to liquid 
nitrogen. While in liquid nitrogen, the Cryotops were covered with caps and dropped 
into the freeze-canes. All the samples were finally stored into a nitrogen tank. 
For thawing, the Cryotops were placed in thawing solution (1 M sucrose; Sigma) 
for 50-60 s at room temperature. They were then moved into 0.5 M sucrose for 3 min, 
followed by 0.25 M sucrose for 3 min at room temperature. All solutions were sup-
plemented with Ham’s F10 containing 20% HSA. The thawed immature oocytes were 
then rinsed 4-5 times in washing solution (Ham’s F-10 + 20% serum). At the end, the 
oocytes were transferred into IVM medium in 50µl droplets. After 48 h incubation, 
maturity and morphology of matured oocytes were assessed. 
Statistical Analysis
Statistical analysis was performed using the SPSS (SPSS 16.0, Chicago, USA) sta-
tistical package. The data were analyzed using the chi-square test. P-value of <0.05 
was considered statistically significant.
Results
A total of 63 (61.2%) oocytes matured by fIVM, while the rate of maturation by vIVM 
was 33.3% (n=34) (P<0.001; Table 1). The number of GV oocytes that matured in vitro 
was significantly higher for fIVM than vIVM oocytes (P<0.001). On the contrary, the 
maturation rates of retrieved MI oocytes were similar between both groups. Fig. 1 pre-
sents the morphological characteristics of GV and MI oocytes, as well as a fIVM oocyte. 
The findings also demonstrated that vitrification-thawing did not have any significant 
impact on the morphological aspect of in-vitro matured oocytes, as the ooplasm color, 
PVS, and oocyte shape were comparable between the two groups (Table 2).
Table 3 presents the correlation of maternal age with oocyte maturation rates. 
The maturation rates in younger women were higher for fIVM. Conversely, in older 
patients, the oocyte maturation rate was higher for vIVM than fIVM. A total of 76, 
105, and 24 immature oocytes were achieved from patients in groups I, II, and III, 
respectively. The highest maturation rate was recorded for the group with male infer-
tility (49.5%). The maturation rates decreased in endometriosis+male infertility and 
ovarian infertility to 45.5% and 44.7%, respectively.
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Discussion
Oocyte freezing is a useful technique for assisted reproduction, particularly in 
cases of malignant diseases, premature ovarian failure, and oocyte donation (Ben-
Ami et al., 2011). Theoretically, GV oocytes are more resistant to cryo-injury because 
they have less depolymerization of the microtubules and are less prone to aneuploidy 
than mature oocytes (Cao et al., 2009). Moreover, a greater number of immature than 
mature oocytes can be retrieved without ovarian stimulation. Therefore, cryopreserva-
tion of immature oocytes may become more useful than that of mature oocytes (Fuchi-
noue et al., 2004; Al-Hasani et al., 2007). During recent years, studies have shown that 
vitrification offers new interesting perspectives in the field of oocyte cryopreservation, 
appearing less traumatic than slow cooling (Cao et al., 2009; Homburg et al., 2009). 
Table 1 – Rates of in vitro maturation of fresh (fIVM) and vitrified oocytes (vIVM).
Groups fIVM vIVM P value
Immature oocytes 63(61.2) 34(33.3) <0.001
GV 47(68.1) 23(34.8) <0.001
MI 16(47.1) 11(30.6) NS
NS= not significant.
Values inside parentheses represent percent (%).
Table 2 – Oocyte morphology before and after in vitro maturation of fresh and vitrified cells.
Groups








Wide PVS Round oocyte
fIVM 0 1 1.9 1.9 3.2 4.8
vIVM 0 1.7 2 50 11.8 14.8
P value NS NS NS <0.001 <0.001 <0.001
PVS = perivitelline space.
NS= not significant.
Values represent percent (%).











Immature oocytes retrieved 61 42 37 65
Matured oocytes (%) 38 (62.3) 25 (59.5) 13 (35.1) 21 (32.3)
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Fig. 1 – Different oocyte aspects: a) Immature germinal vesicle (GV) oocyte, b) Immature metaphase І (MІ) 
oocyte, c) In-vitro matured (MІІ) oocyte, d) dark oocyte, e) non-spherical oocyte, f ) oocyte with wide perivi-
telline space (PVS).
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In conventional IVF cycles, the remaining immature oocytes at the time of collec-
tion are not suitable for intracytoplasmic sperm injection. These immature oocytes, 
upon patient’s agreement, are generally destined to research (Ben-Ami et al., 2011). 
The present study has compared the maturation success of immature oocytes 
obtained from patients upon ovarian stimulation and subjected to fIVM and vIVM. 
It was demonstrated that 61.2% of the oocytes became mature after fIVM. This was 
similar to the data obtained by Nazari et al. (2011) who reported a 59.4% maturation 
rate for fIVM. Also, we found that when immature oocytes were vitrified and then 
matured in-vitro, a significant difference in maturation rate was seen when compared 
with fIVM. It has been shown that vitrification, although a successful cryopreserva-
tion technology, may have a negative effect on the outcome of oocyte maturation. 
Importantly, both groups of fIVM and vIVM showed that the maturation rates of GV 
oocytes were higher than those of MI oocytes. This could be related to chromosomal 
conservation within the membrane of GV. Also, microtubular structures are not yet 
formed in GV oocytes (Nazari et al., 2011). In addition, we found that the rates of 
abnormal oocytes with ovoid shape, dark ooplasm, large and abnormal PVS were 
increased in vIVM oocytes. This indicates that cryopreservation may cause some inju-
ry to the morphological characteristics of oocytes. Therefore, more investigations are 
necessary in order to improve cryotechnology.
In this work, half of the oocytes survived vitrification-thawing, which is similar 
to the findings of Baka et al. (1995). However, other authors showed a lower survival 
rate (Mandelbaum et al., 1988). Recently, Nazari et al. (2011) showed that almost 87% 
of cryopreserved oocytes could survive, but with increasing rates of vacuolization 
and darkening of ooplasm.
In addition, another important factor possibly influencing the maturation of 
human oocytes and investigated in this study is age. The data showed that there 
was no significant relation between patient’s age and the rates of maturation of both 
vIVM and fIVM. Therefore, the maternal age did not influence the maturation rates 
of oocytes in our study. In a large cohort study, Wiser et al. (2011) reported that IVM 
is not suitable for infertile patients over the age of 40. On the basis of the present 
findings, on the contrary, IVM might be practicable for the majority of women seek-
ing assisted reproduction.
In conclusion, our study showed that vitrification is a feasible technique for the 
cryopreservation of immature oocytes, particularly at GV stage, for subsequent appli-
cation in clinical IVM. It is recommended, however, to use the MI oocytes in fresh 
IVM in order to increase the reproductive success, while vitrifying GV oocytes for 
subsequent IVM applications. Further studies are needed to limit the cell injury post 
vitrification.
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